Microbiome Therapeutics Product Applications

2 applications found

Microbiome Therapeutics for Patients and Physicians

Seres’ microbiome therapeutics represent a transformative new approach to ...

BySeres Therapeutics, Inc. based in Cambridge, MASSACHUSETTS (USA)

Microbiome Therapeutics for Clinical Trials

Finch’s lead candidate, CP101, is in late-stage clinical development for the prevention of recurrent C. difficile infection (CDI), and has received Breakthrough Therapy and Fast Track designations from the U.S. Food and Drug Administration. In June 2020, Finch announced that CP101 met its primary efficacy endpoint in PRISM3, the first of two pivotal trials to support the development of CP101 for the prevention of recurrent CDI. PRISM4, a Phase 3 trial, is designed to serve as the second pivotal trial of ...

ByFinch Therapeutics Group, Inc. based in Somerville, MASSACHUSETTS (USA)

Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you